On Tuesday, December 16, 2025, BioCytex, LISM (Laboratory of Macromolecular Systems Engineering - CNRS/Aix-Marseille University), ANR (National Research Agency), and the South Region - Provence-Alpes-Côte d'Azur signed an agreement officially launching the creation of the joint NVDIAG LabCom laboratory.
This LabCom is a strategic alliance resulting from the synergy between BioCytex and LISM around a common ambition: to devise new-generation diagnostic tools by exploiting innovative biological mechanisms to better detect and monitor diseases.
NVDIAG will focus on developing innovative nano-antibodies with the aim of improving diagnostic tests for multiple myeloma and acute leukemias.
